1. Home
  2. PODD vs TU Comparison

PODD vs TU Comparison

Compare PODD & TU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • TU
  • Stock Information
  • Founded
  • PODD 2000
  • TU 1993
  • Country
  • PODD United States
  • TU Canada
  • Employees
  • PODD N/A
  • TU N/A
  • Industry
  • PODD Medical/Dental Instruments
  • TU Telecommunications Equipment
  • Sector
  • PODD Health Care
  • TU Telecommunications
  • Exchange
  • PODD Nasdaq
  • TU Nasdaq
  • Market Cap
  • PODD 19.0B
  • TU 21.8B
  • IPO Year
  • PODD 2007
  • TU N/A
  • Fundamental
  • Price
  • PODD $258.75
  • TU $14.27
  • Analyst Decision
  • PODD Buy
  • TU Hold
  • Analyst Count
  • PODD 17
  • TU 1
  • Target Price
  • PODD $294.65
  • TU $26.00
  • AVG Volume (30 Days)
  • PODD 880.6K
  • TU 3.7M
  • Earning Date
  • PODD 05-08-2025
  • TU 05-08-2025
  • Dividend Yield
  • PODD N/A
  • TU 7.92%
  • EPS Growth
  • PODD 96.55
  • TU 15.14
  • EPS
  • PODD 5.78
  • TU 0.46
  • Revenue
  • PODD $2,071,600,000.00
  • TU $13,996,691,779.00
  • Revenue This Year
  • PODD $20.58
  • TU $6.03
  • Revenue Next Year
  • PODD $17.41
  • TU $3.12
  • P/E Ratio
  • PODD $44.73
  • TU $30.81
  • Revenue Growth
  • PODD 22.07
  • TU 0.67
  • 52 Week Low
  • PODD $160.19
  • TU $13.24
  • 52 Week High
  • PODD $289.46
  • TU $17.27
  • Technical
  • Relative Strength Index (RSI)
  • PODD 44.69
  • TU 39.43
  • Support Level
  • PODD $258.25
  • TU $13.75
  • Resistance Level
  • PODD $276.13
  • TU $15.11
  • Average True Range (ATR)
  • PODD 8.60
  • TU 0.27
  • MACD
  • PODD 0.94
  • TU -0.12
  • Stochastic Oscillator
  • PODD 55.53
  • TU 25.74

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it world-wide.

About TU Telus Corporation

Telus is one of the Big Three wireless service providers in Canada, with over 10 million mobile phone subscribers nationwide constituting about 30% of the total market. It is the incumbent local exchange carrier in the western Canadian provinces of British Columbia and Alberta, where it provides internet, television, and landline phone services. It also has a small wireline presence in eastern Quebec. Mostly because of recent acquisitions, more than 20% of Telus' sales now come from nontelecom businesses, most notably in the international business services, health, security, and agriculture industries. The firm has a 55% economic stake in Telus International.

Share on Social Networks: